Zentalis Pharmaceuticals (ZNTL) Other Gross PP&E Adjustments (2022 - 2025)
Zentalis Pharmaceuticals (ZNTL) has 4 years of Other Gross PP&E Adjustments data on record, last reported at -$24.6 million in Q3 2025.
- For Q3 2025, Other Gross PP&E Adjustments fell 0.7% year-over-year to -$24.6 million; the TTM value through Sep 2025 reached -$24.6 million, down 0.7%, while the annual FY2024 figure was -$30.1 million, 9.88% up from the prior year.
- Other Gross PP&E Adjustments reached -$24.6 million in Q3 2025 per ZNTL's latest filing, up from -$25.6 million in the prior quarter.
- Across five years, Other Gross PP&E Adjustments topped out at -$24.4 million in Q3 2024 and bottomed at -$35.1 million in Q4 2022.
- Average Other Gross PP&E Adjustments over 4 years is -$28.8 million, with a median of -$27.2 million recorded in 2023.
- Peak YoY movement for Other Gross PP&E Adjustments: increased 19.52% in 2023, then fell 4.43% in 2025.
- A 4-year view of Other Gross PP&E Adjustments shows it stood at -$35.1 million in 2022, then increased by 5.01% to -$33.3 million in 2023, then grew by 9.88% to -$30.1 million in 2024, then increased by 18.15% to -$24.6 million in 2025.
- Per Business Quant database, its latest 3 readings for Other Gross PP&E Adjustments were -$24.6 million in Q3 2025, -$25.6 million in Q2 2025, and -$26.3 million in Q1 2025.